2014-005435-14: Combination treatment with DDAVP and factor VIII clotting factor concentrates in patients with mild haemophilia A. Combinatiebehandeling van DDAVP en factor VIII-concentraten in patiënten met milde hemofilie A. |
|
|
| Ongoing | 4 | 60 | Europe | Solution for injection/infusion, Powder and solvent for solution for injection, Minrin, Octostim, Advate, Kogenate Bayer, Helixate NexGen, ReFacto AF, Aafact, Octanate, NovoEight | Erasmus University Medical Center, ZonMw, Ferring BV, Erasmus University Medical Centre | Mild hemophilia A patients with a FVIII plasma levels above 0.05 IU/mL. Milde hemofilie A-patiënten, A clotting disorder in which clotting factor VIII is deficient, which can cause bleeding. In this study we will look at patients with the mild form. Een stollingsstoornis waarin het gehalte van stollingsfactor VIII is verlaagd. Hierdoor kunnen bloedingen veroorzaakt worden. In deze studie kijken we naar patiënten met een milde vorm., Diseases [C] - Blood and lymphatic diseases [C15] | | | | |
2013-000909-24: Study of Pharmacokinetic-guided dosing of clottiing factor in Hemophilia. Studie naar farmacokinetisch gestuurde toediening van stollingsfactoren in hemofilie |
|
|
| Ongoing | 2 | 72 | Europe | Powder and solvent for solution for injection, Powder and solution for solution for injection, , Advate, Kogenate, Helixate NexGen, Refacto, Benefix, Aafact, NovoEight | Erasmus MC, ZON-MW | Hemophillia hemofilie, hemophillia hemofilie, Diseases [C] - Blood and lymphatic diseases [C15] | | | | |
NCT06574984: Study for Turoctocog Alfa Treatment Regimen in Iraqi Haemophilia A Patients |
|
|
| Not yet recruiting | N/A | 900 | NA | Turoctocog alfa, NovoEight | Novo Nordisk A/S | Congenital Bleeding Disorder, Haemophilia A | 11/24 | 11/24 | | |